A Comparison of Brand and Biosimilar Granulocyte-Colony Stimulating Factors for Prophylaxis of Chemotherapy-Induced Febrile Neutropenia.
Douglas AG, Schwab P, Lane D, Kennedy K, Slabaugh SL, Bowe A.
Douglas AG, et al. Among authors: bowe a.
J Manag Care Spec Pharm. 2017 Dec;23(12):1221-1226. doi: 10.18553/jmcp.2017.23.12.1221.
J Manag Care Spec Pharm. 2017.
PMID: 29172983
Free PMC article.
Patients enrolled in a Medicare Advantage Prescription Drug plan with a claim for a G-CSF from October 1, 2015, through September 30, 2016, were identified. ...Douglas, Kennedy, and Slabaugh were employees of Humana Pharmacy Solutions at the time the study wa …
Patients enrolled in a Medicare Advantage Prescription Drug plan with a claim for a G-CSF from October 1, 2015, through …